[HTML][HTML] The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis

…, S Johnson, PDH Wall, A Metcalfe, DG Parr… - Sleep and …, 2020 - Springer
Background Obesity is a common risk factor for polycystic ovary syndrome (PCOS) and
obstructive sleep apnoea (OSA). Both PCOS and OSA are associated with increased risk of type …

Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency

A Dirksen, E Piitulainen, DG Parr… - European …, 2009 - Eur Respiratory Soc
Assessment of emphysema-modifying therapy is difficult, but newer outcome measures offer
advantages over traditional methods. The EXAcerbations and Computed Tomography scan …

Prevalence and Impact of Bronchiectasis in α1-Antitrypsin Deficiency

DG Parr, PG Guest, JH Reynolds… - American journal of …, 2007 - atsjournals.org
Rationale: α 1 -Antitrypsin (AAT) deficiency is associated with increased risk of chronic
obstructive pulmonary disease (COPD), in particular emphysema, but airway disease is less well …

Pattern of emphysema distribution in α1-antitrypsin deficiency influences lung function impairment

DG Parr, BC Stoel, J Stolk… - American journal of …, 2004 - atsjournals.org
FEV 1 is fundamental to the diagnosis and staging of chronic obstructive pulmonary disease.
In emphysema, airflow obstruction usually coexists with impairment of gas exchange, but …

[HTML][HTML] Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using …

RA Stockley, DG Parr, E Piitulainen, J Stolk… - Respiratory …, 2010 - Springer
… David G Parr has served on company advisory board meetings for Talecris Biotherapeutics
and acts as a consultant on the technical steering committees of Talecris Biotherapeutics and …

Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency

DG Parr, BC Stoel, J Stolk, RA Stockley - Thorax, 2006 - thorax.bmj.com
Background: Lung densitometry derived from computed tomographic images offers an
opportunity to quantify emphysema non-invasively, but a pathological standard cannot be applied …

[HTML][HTML] Progression parameters for emphysema: a clinical investigation

J Stolk, H Putter, EM Bakker, SB Shaker, DG Parr… - Respiratory …, 2007 - Elsevier
In patients with airflow limitation caused by cigarette smoking, lung density measured by
computed tomography is strongly correlated with quantitative pathology scores of emphysema, …

[HTML][HTML] Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin …

DG Parr, A Dirksen, E Piitulainen, C Deng… - Respiratory …, 2009 - Springer
Background Computed tomography (CT) lung densitometry has been demonstrated to be
the most sensitive and specific outcome measure for the assessment of emphysema-modifying …

Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography

…, R Edgar, N Quraishi, RA Stockley, DG Parr - American journal of …, 2012 - atsjournals.org
Rationale: Neutrophilic inflammation is understood to be of pathogenetic importance in
chronic obstructive pulmonary disease (COPD) and may be quantified using 18-…

Influence of calibration on densitometric studies of emphysema progression using computed tomography

DG Parr, BC Stoel, J Stolk, PG Nightingale… - American journal of …, 2004 - atsjournals.org
The fundamental importance of calibration for any measuring device is indisputable, but
computed tomography (CT) calibration in longitudinal lung densitometry studies is largely …